Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Cancer Cell|August 25, 2004
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cellsGergely Szakács, Jean-Philippe Annereau, Samir Lababidi, et al.Cancer Research|June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myelomaJing Zhang, Martin Sattler, Giovanni Tonon, et al.Cancer Research|March 5, 2003
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mappingWilliam C Reinhold, Hosein Kouros-Mehr, Kurt W Kohn, et al.Genome Biology|December 9, 2003
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cellsJae K Lee, Kimberly J Bussey, Fuad G Gwadry, et al.Genome Biology|April 19, 2003
GoMiner: a resource for biological interpretation of genomic and proteomic dataBarry R Zeeberg, Weimin Feng, Geoffrey Wang, et al.Scientific Reports|April 8, 2024
Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDABinsheng Gong, Samir Lababidi, Rebecca Kusko, et al.Molecular Cancer Therapeutics|February 3, 2007
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cellsWilliam C Reinhold, Mark A Reimers, Alika K Maunakea, et al.Nature Biotechnology|March 13, 2019
Best practices for benchmarking germline small-variant calls in human genomesPeter Krusche, Len Trigg, Paul C Boutros, et al.Nature Biotechnology|March 23, 2019
Author Correction: Best practices for benchmarking germline small-variant calls in human genomesPeter Krusche, Len Trigg, Paul C Boutros, et al.Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.Pageof 4